Catalyst Wire Dossier Catalyst Wire Dossier

Etavopivat

Etavopivat · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Etavopivat, covering 2025-09-18 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease [Phase 2]

See pricing